Lead Left Arranger News Today

New York, New York, Jan. 25, 2024 -- Oak Hill Advisors served as the Lead Left Arranger of a private unitranche financing for Greenway Health, a provider of electronic health record and practice...

New York, New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors ("OHA") served as the Lead Left Arranger of a private unitranche financing for Greenway Health, a provider of electronic health record and

Bluebird Network, a communications infrastructure provider and operator of more than 11,000 miles of fiber and two data centers, received $285 million of five-year Senior Secured Credit Facilities. Proceeds from the Credit Facilities were used to refinance Bluebird's existing indebtedness and will fund ongoing capital expenditures including network...

/PRNewswire/ -- OHA served as Lead Left Arranger for the private unitranche facility to support Lindsay Goldbergs acquisition of Kleinfelder from Wind Point....

NEW YORK, NY and LOS ANGELES, CA - Global investment firm, Carlyle , today announced it has closed a $175 million term loan to New Regency, a leading independent, founder-owned global...

Carlyle closed a $175 million term loan to New Regency, a leading independent, founder-owned global entertainment company that creates and distributes film, television and documentary content across all platforms. This loan is a refinancing and upsize of an existing Carlyle facility, demonstrating the firm’s confidence in New Regency’s ability to...

05/01/2023 Citizens leads $750 million credit facility for Hexcel Corporation PROVIDENCE, R.I. - Citizens is leading a $750 million senior credit facility for... | May 1, 2023

/PRNewswire/ -- Cetera Financial Group (Cetera), one of Americas largest networks of financial professionals, announced today that it has entered into a...

/PRNewswire/ -- Lampert Capital Advisors, a leading capital markets-focused investment bank, announced today the successful acquisition and related financing...

Share this article Share this article DUBLIN, March 1, 2021 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for total consideration of $1.55 billion, including $1.5 billion in cash, subject to customary adjustments. As part of the consideration, Altaris will also assume more than $50 millio...